Oncternal Therapeutics Inc (ONCT)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
1,558,500
EV to revenue ratio (TTM)
0.853
EV to ebitda
0.147
Financial Performance
Revenue (TTM)
2,161,000
Gross profit (TTM)
-6,515,000
EBITDA
Profitability
Operating margin (TTM)
-1,757.00%
Profit margin
0.00%
Return on assets (TTM)
-76.40%
Return on equity (TTM)
-149.90%
Per Share Metrics
Revenue per share (TTM)
0.73
EPS
-11.69
Diluted EPS (TTM)
-11.69
Book value
3.09
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
0.721
Price to book ratio (TTM)
0.17
Growth
Quarterly earnings growth (YoY)
176.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
Buy
Hold
Sell
Strong sell
Risk & Volatility
Beta
1.33